Abstract
A retrospective analysis of 760 in-patient’s medical cards was performed in order to study a real practice of using drugs, when treating community acquired pneumonia in hospitals of Vinnitsa. The results showed that the patients received on the average 10,18±0,13 drugs for the treatment of community-acquired pneumonia. All the 760 patients obtained antibacterial medicines for a systemic use, one patient received on the average 2,51±0,03 (1 to 7) of them. Nonsteroidal anti-inflammatory drugs, (38,0%), sulphocamphocaine (29,7%), biogenic stimulators (23,2%), vitamins (8,6%) were prescribed quite often. The findings suggest polypragmasia and may serve a basis for planning a set of measures to improve pharmacotherapy of community-acquired pneumonia.
Highlights
Распространено мнение о необходимости их назначения параллельно с антибактериальных препаратов (АБП) для профилактики дисбактериоза [4]
STRUCTURE OF DRUG PRESCRIPTIONS IN THE TREATMENT OF COMMUNITYACQUIRED PNEUMONIA IN HOSPITALS (DURING 2012)
Summary
Том 17, No 1 (65), 2013 щелочной фосфатазы» в трофобласте хориальных ворсинок при различных видах воспаления последа.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
